Scheen, André J <br/><br/>
Pharmacokinetics and clinical evaluation of the alogliptin plus pioglitazone combination for type 2 diabetes.  [electronic resource] 

 -  Expert opinion on drug metabolism & toxicology  Jun 2015 
 - 1005-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7607 
<br/><br/><label>Standard No.: </label>10.1517/17425255.2015.1041499  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Glucose--drug effects<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dipeptidyl-Peptidase IV Inhibitors--administration & dosage<br/>Drug Combinations<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Insulin--metabolism<br/>Pioglitazone<br/>Piperidines--administration & dosage<br/>Thiazolidinediones--administration & dosage<br/>Uracil--administration & dosage